Prostate cancer patients with metastatic disease and low-volume primary tumors appear to have a poor prognosis, according to ...

Cancer is still the most common cause of death for men in the US ages 60 to 79 and women ages 40 to 79. For all adults ...

Cancer survival in the U.S. has climbed to 70%, reflecting major advances in treatment, early detection and personalized care ...

The latest edition of an annual report finds new cases continue to rise and outcomes have worsened for some cancers.

University Hospitals Seidman Cancer Center researchers have developed a tool that could identify metastatic prostate cancer ...

Researchers found better detection, treatment and decreased smoking have been immensely helpful in reducing deaths due to ...

Dr. Kent Perry answers the question: 'Predicting Prognosis Of Prostate Cancer?' March 16, 2009 -- Question: What predicts the prognosis of your prostate cancer? Answer: The prognosis of prostate ...

Cartoonist Scott Adams died at 68 after a prolonged battle with prostate cancer. To know what its symptoms, causes, ...

A life-extending prostate cancer drug is to be made available to thousands of men in England in a matter of weeks, after a ...

Researchers at the UCLA Health Jonsson Comprehensive Cancer Center have launched a clinical trial, called ANDROMEDA, to ...

When prostate cancer spreads beyond the prostate gland to other parts of the body, it becomes what medical professionals call metastatic prostate cancer. This advanced form of the disease represents a ...

The known prostate cancer drug, Abiraterone, will be accessible for patients in the coming week, after a campaign led by a ...